Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3

Conditions

Breast Neoplasms 8Endometrial Neoplasms 3Colonic Neoplasms 3Rectal Neoplasms 2Mouth Neoplasms 2Melanoma 2Colorectal Neoplasms 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Rhabdomyosarcoma 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Head and Neck Neoplasms 1Carcinoma 1Breast Neoplasms, Male 1

Interventions

Paclitaxel 95Carboplatin 77pembrolizumab 74Cisplatin 29Bevacizumab 27Letrozole 22Radiotherapy 21Doxorubicin 21Megestrol Acetate 20lenvatinib 19olaparib 18Taxes 17Docetaxel 17Nivolumab 16Specimen Handling 15Metformin 15dostarlimab 14Magnetic Resonance Spectroscopy 14Gemcitabine 13durvalumab 12Medroxyprogesterone Acetate 12Trastuzumab 11Indocyanine Green 11Fulvestrant 11Biopsy 11temsirolimus 10abemaciclib 10atezolizumab 9Radiation 9Early Intervention, Educational 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Endometrial Neoplasms × iso-sulfan blue × Clear all
NCT01818739 2023-03-22

Lymph Node Mapping in Patients With Endometrial Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Completed
204 enrolled 4 charts
Gynecologic

Endometrial Neoplasms

NCT01939028 2020-08-27

Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery

Case Comprehensive Cancer Center

Phase NA Terminated
58 enrolled 12 charts
Gynecologic

Endometrial Neoplasms

NCT02589366 2018-10-15

Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium

University of California, San Diego

Phase 1 Terminated
2 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡